QuidelOrtho (QDEL) Competitors

QuidelOrtho logo
$9.57 -0.30 (-3.04%)
Closing price 04:00 PM Eastern
Extended Trading
$9.62 +0.05 (+0.52%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

QDEL vs. NEOG, UFPT, XRAY, AVNS, and CERS

Should you buy QuidelOrtho stock or one of its competitors? QuidelOrtho's main competitors and comparable companies include Neogen (NEOG), UFP Technologies (UFPT), DENTSPLY SIRONA (XRAY), Avanos Medical (AVNS), and Cerus (CERS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does QuidelOrtho compare to Neogen?

Neogen (NASDAQ:NEOG) and QuidelOrtho (NASDAQ:QDEL) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

Neogen has higher earnings, but lower revenue than QuidelOrtho. Neogen is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neogen$870.40M2.73-$7.90M-$0.25N/A
QuidelOrtho$2.73B0.25-$1.13B-$5.41N/A

Neogen has a net margin of -6.35% compared to QuidelOrtho's net margin of -14.24%. Neogen's return on equity of 3.29% beat QuidelOrtho's return on equity.

Company Net Margins Return on Equity Return on Assets
Neogen-6.35% 3.29% 2.06%
QuidelOrtho -14.24%3.22%1.03%

Neogen currently has a consensus price target of $12.67, suggesting a potential upside of 16.21%. QuidelOrtho has a consensus price target of $13.63, suggesting a potential upside of 38.04%. Given QuidelOrtho's higher possible upside, analysts clearly believe QuidelOrtho is more favorable than Neogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neogen
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
QuidelOrtho
2 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

96.7% of Neogen shares are held by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are held by institutional investors. 0.5% of Neogen shares are held by company insiders. Comparatively, 1.1% of QuidelOrtho shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Neogen has a beta of 1.86, meaning that its share price is 86% more volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market.

In the previous week, QuidelOrtho had 2 more articles in the media than Neogen. MarketBeat recorded 8 mentions for QuidelOrtho and 6 mentions for Neogen. Neogen's average media sentiment score of 0.59 beat QuidelOrtho's score of 0.57 indicating that Neogen is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Neogen
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
QuidelOrtho
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Neogen beats QuidelOrtho on 10 of the 16 factors compared between the two stocks.

How does QuidelOrtho compare to UFP Technologies?

UFP Technologies (NASDAQ:UFPT) and QuidelOrtho (NASDAQ:QDEL) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings.

QuidelOrtho has a consensus target price of $13.63, suggesting a potential upside of 38.04%. Given QuidelOrtho's higher possible upside, analysts plainly believe QuidelOrtho is more favorable than UFP Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UFP Technologies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
QuidelOrtho
2 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

UFP Technologies has higher earnings, but lower revenue than QuidelOrtho. QuidelOrtho is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UFP Technologies$602.80M3.82$68.31M$9.8130.33
QuidelOrtho$2.73B0.25-$1.13B-$5.41N/A

In the previous week, QuidelOrtho had 7 more articles in the media than UFP Technologies. MarketBeat recorded 8 mentions for QuidelOrtho and 1 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 0.91 beat QuidelOrtho's score of 0.57 indicating that UFP Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UFP Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
QuidelOrtho
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

UFP Technologies has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market.

UFP Technologies has a net margin of 11.78% compared to QuidelOrtho's net margin of -14.24%. UFP Technologies' return on equity of 18.46% beat QuidelOrtho's return on equity.

Company Net Margins Return on Equity Return on Assets
UFP Technologies11.78% 18.46% 12.41%
QuidelOrtho -14.24%3.22%1.03%

87.3% of UFP Technologies shares are held by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are held by institutional investors. 4.6% of UFP Technologies shares are held by insiders. Comparatively, 1.1% of QuidelOrtho shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

UFP Technologies beats QuidelOrtho on 11 of the 15 factors compared between the two stocks.

How does QuidelOrtho compare to DENTSPLY SIRONA?

QuidelOrtho (NASDAQ:QDEL) and DENTSPLY SIRONA (NASDAQ:XRAY) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

QuidelOrtho has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

In the previous week, DENTSPLY SIRONA had 2 more articles in the media than QuidelOrtho. MarketBeat recorded 10 mentions for DENTSPLY SIRONA and 8 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 0.57 beat DENTSPLY SIRONA's score of -0.04 indicating that QuidelOrtho is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QuidelOrtho
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
DENTSPLY SIRONA
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

99.0% of QuidelOrtho shares are owned by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 1.1% of QuidelOrtho shares are owned by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

QuidelOrtho presently has a consensus price target of $13.63, suggesting a potential upside of 38.04%. DENTSPLY SIRONA has a consensus price target of $12.08, suggesting a potential upside of 40.50%. Given DENTSPLY SIRONA's stronger consensus rating and higher possible upside, analysts plainly believe DENTSPLY SIRONA is more favorable than QuidelOrtho.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QuidelOrtho
2 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
DENTSPLY SIRONA
4 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
1.93

DENTSPLY SIRONA has higher revenue and earnings than QuidelOrtho. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QuidelOrtho$2.73B0.25-$1.13B-$5.41N/A
DENTSPLY SIRONA$3.68B0.46-$598M-$0.62N/A

DENTSPLY SIRONA has a net margin of -3.38% compared to QuidelOrtho's net margin of -14.24%. DENTSPLY SIRONA's return on equity of 20.21% beat QuidelOrtho's return on equity.

Company Net Margins Return on Equity Return on Assets
QuidelOrtho-14.24% 3.22% 1.03%
DENTSPLY SIRONA -3.38%20.21%5.15%

Summary

DENTSPLY SIRONA beats QuidelOrtho on 12 of the 16 factors compared between the two stocks.

How does QuidelOrtho compare to Avanos Medical?

QuidelOrtho (NASDAQ:QDEL) and Avanos Medical (NYSE:AVNS) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership, media sentiment and analyst recommendations.

QuidelOrtho has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market.

Avanos Medical has a net margin of -10.39% compared to QuidelOrtho's net margin of -14.24%. Avanos Medical's return on equity of 5.39% beat QuidelOrtho's return on equity.

Company Net Margins Return on Equity Return on Assets
QuidelOrtho-14.24% 3.22% 1.03%
Avanos Medical -10.39%5.39%3.97%

Avanos Medical has lower revenue, but higher earnings than QuidelOrtho. Avanos Medical is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QuidelOrtho$2.73B0.25-$1.13B-$5.41N/A
Avanos Medical$715.90M1.64-$72.90M-$1.61N/A

In the previous week, QuidelOrtho had 7 more articles in the media than Avanos Medical. MarketBeat recorded 8 mentions for QuidelOrtho and 1 mentions for Avanos Medical. QuidelOrtho's average media sentiment score of 0.57 beat Avanos Medical's score of 0.00 indicating that QuidelOrtho is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QuidelOrtho
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Avanos Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

QuidelOrtho presently has a consensus price target of $13.63, indicating a potential upside of 38.04%. Given QuidelOrtho's stronger consensus rating and higher probable upside, analysts clearly believe QuidelOrtho is more favorable than Avanos Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QuidelOrtho
2 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Avanos Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

99.0% of QuidelOrtho shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 1.1% of QuidelOrtho shares are owned by company insiders. Comparatively, 2.3% of Avanos Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Avanos Medical beats QuidelOrtho on 8 of the 15 factors compared between the two stocks.

How does QuidelOrtho compare to Cerus?

QuidelOrtho (NASDAQ:QDEL) and Cerus (NASDAQ:CERS) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

Cerus has a net margin of -3.23% compared to QuidelOrtho's net margin of -14.24%. QuidelOrtho's return on equity of 3.22% beat Cerus' return on equity.

Company Net Margins Return on Equity Return on Assets
QuidelOrtho-14.24% 3.22% 1.03%
Cerus -3.23%-10.44%-3.42%

QuidelOrtho currently has a consensus price target of $13.63, suggesting a potential upside of 38.04%. Cerus has a consensus price target of $5.25, suggesting a potential upside of 176.32%. Given Cerus' stronger consensus rating and higher possible upside, analysts clearly believe Cerus is more favorable than QuidelOrtho.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QuidelOrtho
2 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Cerus
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

99.0% of QuidelOrtho shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 1.1% of QuidelOrtho shares are held by insiders. Comparatively, 5.3% of Cerus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

QuidelOrtho has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market. Comparatively, Cerus has a beta of 1.84, meaning that its share price is 84% more volatile than the broader market.

In the previous week, QuidelOrtho had 7 more articles in the media than Cerus. MarketBeat recorded 8 mentions for QuidelOrtho and 1 mentions for Cerus. Cerus' average media sentiment score of 0.91 beat QuidelOrtho's score of 0.57 indicating that Cerus is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QuidelOrtho
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Cerus
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cerus has lower revenue, but higher earnings than QuidelOrtho. Cerus is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QuidelOrtho$2.73B0.25-$1.13B-$5.41N/A
Cerus$206.13M1.86-$15.63M-$0.03N/A

Summary

Cerus beats QuidelOrtho on 10 of the 16 factors compared between the two stocks.

Get QuidelOrtho News Delivered to You Automatically

Sign up to receive the latest news and ratings for QDEL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QDEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QDEL vs. The Competition

MetricQuidelOrthoHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$677.21M$5.92B$7.60B$11.72B
Dividend YieldN/A1.68%2.47%4.48%
P/E Ratio11.4838.8433.5830.13
Price / Sales0.245.688.275.60
Price / Cash0.5223.6221.0121.90
Price / Book0.374.214.443.72
Net Income-$1.13B$143.14M$3.50B$393.88M
7 Day Performance-19.65%-5.62%-6.53%-6.07%
1 Month Performance-25.87%-3.77%-4.93%-7.38%
1 Year Performance-55.03%-0.16%-1.73%-7.48%

QuidelOrtho Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QDEL
QuidelOrtho
3.7146 of 5 stars
$9.57
-3.0%
$13.63
+42.4%
-53.2%$677.21M$2.73B11.486,500
NEOG
Neogen
2.5117 of 5 stars
$12.08
+2.7%
$12.67
+4.9%
+69.8%$2.72B$870.40MN/A1,257
UFPT
UFP Technologies
1.4127 of 5 stars
$318.86
+5.1%
N/A+33.5%$2.55B$602.80M30.775,349
XRAY
DENTSPLY SIRONA
3.4536 of 5 stars
$9.54
+0.8%
$12.42
+30.2%
-17.2%$2.12B$3.68BN/A14,000
AVNS
Avanos Medical
0.0288 of 5 stars
$24.99
flat
N/AN/A$1.17B$715.90MN/A4,040

Related Companies and Tools


This page (NASDAQ:QDEL) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners